[177Lu]Ludotadipep

DRUG2 trials

Sponsors

FutureChem

Conditions

Metastatic Castration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer, mCRPC

Phase 1

[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.

CompletedNCT04509557

FutureChemMetastatic Castration-resistant Prostate Cancer

Start: 2020-10-14End: 2022-06-30Updated: 2022-10-20

Phase 2

[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2

Active, not recruitingNCT05579184

FutureChemMetastatic Castration-resistant Prostate Cancer, mCRPC

Start: 2022-10-30End: 2024-12-31Target: 20Updated: 2024-04-29